Practical Management of Early Stage HER2+ Breast Cancer


Nurse practitioners provide insight on issues surrounding the administration of dual HER2-targeted therapy in the neoadjuvant/adjuvant setting and counseling patients on common AEs associated with trastuzumab-pertuzumab for the treatment of HER2+ breast cancer.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.